Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Shows potential in the development of anxiolytic and anticonvulsant agents due to its interaction with GABA receptors. Also explored for its anti-inflammatory properties in preclinical studies. Its trifluoromethyl group enhances metabolic stability, making it valuable in drug design for improving pharmacokinetic profiles.